Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients

Second-generation tyrosine kinase inhibitors (2G-TKIs) are effective at inducing complete cytogenetic responses (CCyRs) in approximately half of chronic myeloid leukemia patients treated while still in the chronic phase and after failing imatinib. It is less clear whether these responses are durable...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Milojkovic, Dragana, Apperley, Jane F., Gerrard, Gareth, Ibrahim, Amr R., Szydlo, Richard, Bua, Marco, Reid, Alistair, Rezvani, Katayoun, Foroni, Letizia, Goldman, John, Marin, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2012
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5162552/
https://ncbi.nlm.nih.gov/pubmed/22174159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-383000
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak